Who to call at ABVC BioPharma, Inc., and when
Fundz watches for the moments ABVC BioPharma, Inc. starts buying, and tells you who to reach.
- An alert the day ABVC BioPharma, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ABVC BioPharma, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ABVC BioPharma, Inc.. With Fundz connected, it knows.
ABVC BioPharma, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
abvcpharma.comAI Executive Summary
AI-powered analysis of 8-K filing content
ABVC BioPharma's Compensation Committee approved a Performance Incentive Plan for directors and officers, effective only if the company achieves a $1B market capitalization for 30 consecutive trading days on or before December 31, 2027. Awards are capped at $10 million in total and $1 million per recipient, with shares equal to 1% of common stock outstanding sourced from the 2016 Equity Incentive Plan.
Key Takeaways
The plan activates only if ABVC reaches a $1B market cap for 30 consecutive trading days by December 31, 2027, and the company states this outcome is not guaranteed.
Total awards are capped at $10 million and individual grants at $1 million per recipient, subject to exceptions the Board may approve.
2 more takeaways
Related Filings (4)
4 more filings from ABVC BioPharma, Inc. in the last 90 days
Filing Overview
What This Means
ABVC BioPharma, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.